The maker of pipe fittings, couplings, valves and accessories is opening a new branch location, about 170 miles southwest of ...

The 46th Tri-C JazzFest runs Friday through Saturday indoors and out at Playhouse Square. This year's festival provides opportunities for new audiences to connect with jazz.

An eclectic cornucopia of sounds and styles is about to take over Cleveland’s Playhouse Square again. It’s time for the Tri-C JazzFest, which takes place June 26 through 28 with eight ticketed ...

"Tri-C truly meets students where they are, providing the resources and support they need to be successful while they are here and creating a sense of belonging," she said in a statement. "I look ...

Valve founder Gabe Newell’s neural chip company Starfish Neuroscience announced it’s developing a custom chip designed for next-generation, minimally invasive brain-computer interfaces—and ...

After a 1-5 start to its season, Tri-C's baseball team heads into the postseason on a 40-game winning streak powered by an explosive offense.

N.Y.C. Helicopter Company Shuts Operations After Deadly Crash, F.A.A. Says All six people on board the craft, operated by New York Helicopter Tours, died when it crashed into the Hudson River on ...

INCLINE VILLAGE, Nev., April 02, 2025 (GLOBE NEWSWIRE) -- Tri Pointe Homes ® (NYSE: TPH), one of the largest homebuilders in the U.S., has once again been named to the Fortune 100 Best Companies ...

Five years after Half-Life: Alyx reshaped expectations for VR gaming, Valve remains a quiet yet critical force in the industry. Despite little fanfare, the company has continued to shape the VR ...

According to Valve, Bucher in July, 2023, offered to settle nearly 45,000 cases for a flat rate of $2,400 a piece, plus another $1,600 to cover legal fees — a demand that the company in court ...

The legal battle was such a drain on Valve's resources that the company nearly went bankrupt. Newell also revealed that he was nearly personally bankrupted as well, and he had to put up his house ...

The valve-replacement group had fewer wins than the control group with respect to the annualized rate of hospitalization for heart failure (9.7% vs. 10.0%).